Join the Pharmaceutical Reserve Network today!
Radical Simplicity. More Reliability.
Through the Pharmaceutical Reserve Network, Vanguard has simplified the entire manufacturing and fill-finish process so any manufacturer — large or small — can enter the generic injectables industry and start supplying their local markets with the medicines they urgently need.
Exclusivity and Efficiency
At the core of our manufacturing solution is Blow-Fill-Seal (BFS), an advanced aseptic filling process that can achieve high efficiency with low operations cost and minimal labor. Vanguard provides the bulk unfinished drug, and the affiliate fills and finishes it using BFS technology.
The Pharmaceutical Reserve Network gives each affiliate an exclusive territory to service with their finished injectable pharmaceuticals — helping to ensure sufficient demand across the dozens of in-demand medicines Vanguard has in stock.
Bringing Technology Together
Lower Costs, Reliable Products, Good Profit
Affiliates of the Pharmaceutical Reserve Network earn significantly higher profit than traditional glass filling lines thanks to Vanguard’s simple supply chain and automated BFS System.
Our automated BFS System is prefabricated for simpler installation, and has significantly lower OpEx and CapEx costs than traditional glass filling lines — allowing our affiliates to sell their injectables at very competitive prices and still earn a good profit margin.